Furosemide (IV)

Furosemide (IV)

Form: Intravenous (IV) injection

Strength: 10 mg/mL

Reference Brands: Lasix®(US & EU)

Category: Critical Care

Furosemide (IV), a potent loop diuretic, is widely used to treat acute pulmonary edema, congestive heart failure, and fluid overload. Available in 10 mg/mL strength, it is supplied in 2 mL to 10 mL ampoules or vials for rapid intravenous administration. Branded as Lasix® and available through generics in the US and EU, furosemide ensures quick diuresis in emergency and critical care settings. Pharma B2B platforms offer bulk sourcing of GMP-compliant Furosemide IV from certified global manufacturers. Ensure hospital-grade quality, regulatory compliance, and continuous availability for healthcare providers managing acute fluid imbalance and cardiac conditions.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.